|
| |
|
| |
 |
|
| |
Our mission is to deliver best value to the benefit of patients,clients,employees and government through
innovation,trust,speed,quality,global orientation,sound business management and dedication to excellent service. |
|
|
 
14th Annual Clinical Trial Supply Europe
Meet with Depot Meridian at 26-27 Feb Berlin Germany
DEPOT MERIDIAN YOUR CLINICAL TRIAL SUPPLIES MANAGEMENT SOLUTIONS IN TURKEY
|
|
Progressive Outsourcing Partnerships for Clinical Trials
Meet with Mene Research at 11-12 February Paris France
|
|
Sule Mene, MD Steering Commitee of Promoting Clinical Trials MENA conference series
First in the global series Promoting Clinical Trials MENA is launched, with the first one focusing on the Middle East and North Africa (MENA) and Turkey. The conference will be taking place in Dubai, UAE during the 3 - 4 October 2012. Sule Mene is one of the steering committee member who helped to ensure the right topics are covered to highlight current issues, challenges and more importantly, explore the opportunities the region presents
http://www.promotingclinicaltrials.com/steering_committee.aspx
|
|
Clinical Trials in Turkey - 2012 Perspective
Sule Mene, CEO of Mene Research will be presenting "Inspection experience of a CRO" at Clinical Trials in Turkey - 2012 Perspective, on the 16th of February in Istanbul. This conference has been arranged in collaboration with EUCROF and SAKDER.
|
|
Upcoming Exhibition
Mene Research will be exhibiting in the 12th Annual Clinical Trial Supply conference on 22-23 February, London, UK. You can find us at booth number 29.
For more information please check:
http://www.arena-international.com/ctseurope/sponsors/
|
|
MENE Research Partners with TAKE Solutions
TAKE - MENE partnership to offer a wide range of strategic solutions and services catering to the growing needs for Drug Safety Solutions in Pharma Emerging Nations.
For more information please check:
http://www.takesolutions.com/images/press/TAKE-Solutions-Partners-with-MENE-Research.pdf
|
|
Mene Research Global LLC Anniversary Celebrations
Dr.Sule Mene and Dr.Tolga Mene jointly initiated the anniversary celebrations of Mene Research Global LLC offices in BWTech@UMBC, Baltimore,MD.
"The expertise and open mind of our ex-FDA colleagues in our Baltimore office enables us to understand pharma and medical device clients' needs better and to be prepared for the upcoming regulatory changes in USA especially in medical devices. " says Dr.Tolga Mene, Director of Mene Research Global LLC.
|
|
Merhaba Turkey,Opportunity Knocks
In June 2011 edition of Pharma Voice Magazine, an article about Turkey has just been published : Merhaba Turkey,Opportunity Knocks.
CEO of Mene Research, Dr.Sule Mene is amongst the 4 honored authors of this article.
Full version of the article can be accessed at http://viewer.zmags.com/publication/d43f8bfc?page=44#/d43f8bfc/47
|
|
Azidus Labs selected Mene Research for BA/BE inspection
Azidus Labs has selected Mene Research in late December 2010 to act as its legal representative in Turkey for approval process of their bioavailability and bioequivalence premises in Chennai, India.
Azidus Labs had been inspected by Turkish Ministry of Health in February,2011 and received approval in April,2011.
|
|
Ankara office opened
Mene Research continues to expand its domestic operations and last breakthrough to support innovation was to establish new office in Ankara, Turkey. "Ankara's unique location, access to quality investigators and research and our stron relations with Hacettepe University Technopolis resulted in a way to open new office in Hacettep İvedik Technopolis. This office will serve to researchers in the medical industry a gateway to commercialize their products" says Arda Karaduman, Head of Business Development
|
|
Medical Innovation Platform Meeting
Mene Research has been presented with two executives in the Medical Innovation Platform Meeting held on 25/02/2011 in Ankara. The meeting hosted a number of valuable guests including government, academics and industry people. Dr.Sule Mene presented "How Turkey can enter into top 10 in clinical research market?" and Dr.Tolga Mene presented "Medical Devices Clinical Research" to download presentations www.mediplat.com.tr
|
|
Medical Innovation Platform Meeting
Medikal alanda onemli bir birikime sahip Hacettepe Universitesi, Hacettepe Teknokent ve Hacettepe Teknokent Teknoloji Transfer Merkezi ve Mene Research onderliginde Medikal Inovasyon Platformu kurulması icin calışmalar baslatılmıştır. Bu calısmaların ilk basamagı olan Medikal Inovasyon Platformu Konferansı ilk toplantısını 25 Şubat 2011 tarihinde Ankarada gercekleştirecektir. Konferans programı ve detaylı bilgi icin web sitesi www.mediplat.com
|
|
MeneResearch is present in Phase I Clinical Trials Summit
MeneResearch is present in Phase I Clinical Trials Summit / Strategies for improving Phase I trial design, management and execution 28th - 29th October 2010, BSG House, London, UK VP, Clinical Development of MeneResearch: Dr. Assem S. el Baghdady, MD, MBA is presenting "The use of biomarkers early in clinical development" 1-Biomarkers as go/no-go in early clinical development 2-Do biomarkers worth the cost or the time? 3-Can we use biomarkers in late clinical development too? 4-What role do biomarkers play in the clinic? For more information contact : assem@meneresearch.com
|
|
Mene Research is attending The 4th Annual Invitation-Only Summit
The 4th Annual Invitation-Only Summit forMedical Device and Diagnostics Chief Compliance Officers which will be held in June 8,9 2010 at Boston,USA. This Summit has been designed to encourage an open exchange of ideas and strategies surrounding some of the most critical issues facing compliance and legal departments in the medical device and diagnostic industry. Participants can share their challenges in these areas, pose questions of their colleagues and come away with valuable insights into current and future compliance strategies. An antitrust attorney is present throughout the Summit to ensure appropriate and compliant discussion among participants
|
|
Sule Mene is to speak at MAGI Conference
Mene Research CEO Sule Mene is being invited to speak at MAGI Clinical Research Conference which will be held on 23-26 May 2010 at Boston,USA. As an expert Dr.Mene will be speaking in a debate session to inform the audience about clinical research . Conference website is http://www.magiworld.org/events/2010E
|
|
MENE Research is exhibiting at EBAN Congress 2010
Representatives of the early stage investor community will meet in Istanbul on April 15th and 16th 2010 on the occasion of EBAN's (European Business Angels Network) 10th Annual Congress and 5th Award Ceremony. This event is the leading awareness raising gathering of early stage investors in Europe and will be organised by EBAN and the Middle East Technical University's Technopolis' business angel network - METUTECH-BAN. The event aims to share best practices, raise awareness and build relations among thousands of investors and other financial actors involved in closing the equity gap and interested in collaborating and investing together. Through the years, the event has provided a key contribution to the growth and consolidation of the angel market in Europe, leading the creation of an increasing number of business angel networks and other related partnerships and collaborations across Europe. EBAN is a non-profit association representing the interests of business angels, business angels networks (BANs), seed funds and other entities involved in bridging the equity gap in Europe.
|
|
UK office opened
Mene Research opens its first office in Europe in Surrey,United Kingdom. Mene Research CEO Sule Mene tells that this is just the beginning of a new era for the company and expansion will continue to Europe and Middle East.
|
|
Mene Research @3rd Annual CEE & CIS Clinical Trials Forum
Mene Research has become the collaborative sponsor of 3rd Annual CEE & CIS Clinical Trials Forum which will be held in Vienna on 24-25 February 2010. Mene Research will have a booth there waiting for interested parties
|
|
MENE Research to join Leading Chief Scientific Officers at the Evolution Summit
MENE Research, a Turkish Clinical Research Organisation (CRO) headquartered in GOSB Science Park nearby Istanbul, Turkey and providing excellent coverage worldwide, is scheduled to meet one-to-one with attendees of this prestigious event as a direct platform for highlighting the services offered by MENE Research. Mene Research is �the first approved CRO by the Ministry of Health in Turkey� after having been inspected in 2009 by the Turkish Ministry of Health for Quality Management Systems, including SOPs and working principles. Established in 2002, Mene Research combines the advantage of a medium-size international CRO with local presence and local expertise offering Project Management, Site Management & Monitoring, Supply Management & Warehousing, Data Management & Biostatistics, Electronic Data Capture (EDC), Medical Writing & Translation, Regulatory Affairs, Quality Assurance & Auditing, Pharmacovigilance, GCP Training and Drug Development & Due Diligence. Flexibility, dynamism, personal dedication, simple company structure and local knowledge enables Mene Research is able to offer high value service. Mene Research also offers cold chain warehouse and logistics solutions under the 'Depot Meridian' brand for any kind of study supplies logistics. Depot Meridian is also inspected and became the first and only approved clinical trial specific warehouse in Turkey in February, 2010. For more information please visit their homepage: www.meneresearch.com The Evolution Summit (www.evolution-summit.com/MENEr), offers the perfect setting to present products and services directly to the key decision makers and gate keepers of the immense global development budgets. Over three days, sponsors will meet and interact with top pharmaceutical and biotechnology executives through a number of business one-to-one meetings and many networking activities. At the Evolution Summit, attendees will follow a personalised agenda designed to maximise their limited time and to effectively meet their business needs and interests. The speakers include: Kenneth Chien, Director of the Cardiovascular Research Center, Massachusetts General Hospital, Professor of Stem Cell & Regenerative Biology, Harvard University; Diarmuid Jeffreys, Author, �Aspirin: The Remarkable Story of a Wonder Drug�; Jonathan Knowles, Professor of Translational Medicine, Ecole Polytechnique Federale de Lausanne & Former President of Group Research, F. Hoffmann-La Roche & Board Member, Genentech; Joris Van Dam, IT Director Health Information Technology, Health Information Science, Johnson & Johnson and Anna Matranga, Head of Global Purchasing & Outsourcing, Galderma R&D. MENE Research representatives will have a number of pre-scheduled meetings with Chief Scientific Officers, Chief Medical Officers, Vice Presidents of Clinical Research and Development, Directors of Scientific and Medical Affairs, Heads of Clinical Operations and Heads of Early Clinical Development & Exploratory Science. Please note that the Evolution Summit is an invitation only business event.
|
|
Clininical Research Symposium has been held on 13-14 March 2009 Istanbul/TURKEY
1st day of Symposium an information has been given European Clinical Research infrastructures Network ( ECRIN), on 2nd day the discussion was how the new Turkish Clinical Research regulations and guidelines are affecting in our practice... Our Managing Director Sule Mene repesents the CRO business at the panel discussion session Please click on for symposium agenda
|
|
The title of "CRO responsibilities" session has been presented during the new regulation training me
This training meeting has been organized by AIFD, meeting program has been conducted by MoH of the Turkish Republic Pharmaceutical General Directorate. More than 250 attendees were present from CROs and Pharmaceutical companies for understanding the new regulation and procedures.
|
|
Mene Research had a Regulatory inspection by the authority MoH
During the month of January 2009, MENE Clinical Research Organisation office and Depot Meridian office completed a successful inspection process by the Local Regulatory Authorities. This inspection was performed to review the activities and the procedures of running set up and SOPs
|
|
|
|
|
|
